Accounts Receivables - Rosetta Genomics Ltd (OTC:ROSGQ) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.0001 USD

Updated:

Rosetta Genomics Ltd
Accounts Receivables

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Rosetta Genomics Ltd
Accounts Receivables Peer Comparison

CLGN

KMDA

URGN

ENTX

B

BONS

Company		Accounts Receivables	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Rosetta Genomics Ltd OTC:ROSGQ	Accounts Receivables $2.9m	CAGR 3-Years 133%	CAGR 5-Years 204%	CAGR 10-Years N/A
	Collplant Biotechnologies Ltd NASDAQ:CLGN	Accounts Receivables $0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Kamada Ltd NASDAQ:KMDA	Accounts Receivables $18.9m	CAGR 3-Years -3%	CAGR 5-Years -4%	CAGR 10-Years 4%
	Urogen Pharma Ltd NASDAQ:URGN	Accounts Receivables $14.2m	CAGR 3-Years 31%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Entera Bio Ltd NASDAQ:ENTX	Accounts Receivables $0	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
B	Bonus Biogroup Ltd TASE:BONS	Accounts Receivables ₪464k	CAGR 3-Years -11%	CAGR 5-Years 1%	CAGR 10-Years -3%

See Also

Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Accounts Receivables amounts to 2.9m USD.

Over the last year, the Accounts Receivables growth was -22%. The average annual Accounts Receivables growth rates for Rosetta Genomics Ltd have been 133% over the past three years , 204% over the past five years .

Join more than 142,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.